Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...
Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...
First-in-human study evaluates dual-target, dual-payload ADC in advanced ovarian cancer and other solid tumours Phrontline ...
Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...
Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the ...
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data ...
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.
Discontinuations by stated reason and by phase, APAC sponsors, 1 January to 30 September 2026. Source: BioPharma APAC ...
Hengrui Pharma announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready ...
Link Cell Therapies ("Link"), an oncology cell therapy company utilizing its proprietary logic-gating technology to develop ...
It has been evaluated across multiple clinical studies in patients with CLL/SLL who were either previously treated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results